NRIX EBITDA Growth
Nurix Therapeutics Inc · EBITDA Growth
NRIX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported243.07%period ending
NRIX TTM EBITDA YoY % (-215.88% → 243.07%)
Year-over-year change
High-resolution chart · PNG
NRIX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 243.0704% | |
| -71.8071% | |
| -44.093% | |
| -38.4291% | |
| -40.2016% | |
| -26.1145% | |
| -47.0314% | |
| -35.7476% | |
| -18.4548% | |
| -3.2428% | |
| 21.9056% | |
| 23.154% | |
| 14.8645% | |
| -0.089% | |
| -30.4635% | |
| -52.1055% | |
| -64.0329% | |
| -65.276% | |
| -71.3629% | |
| -77.4915% | |
| -72.2199% | |
| -119.8605% | |
| -151.0767% | |
| -215.8787% |